Skip to content

Electromagnetictherapy for treatment of insomnia

Randomized-controlled trial on Electromagnetictherapy for treatment of insomnia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201112128382N1
Enrollment
60
Registered
2011-12-28
Start date
2007-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary insomnia. A condition of unsatisfactory quantity and/or quality of sleep, which persists for a considerable period of time, including difficulty falling asleep, difficulty staying asleep, or early final wakening. Insomnia is a common symptom of many mental and phys

Interventions

Intervention 1: In the treatment group, patients treated with electromagnetic therapy and 3 weeks for 6 sessions, each session 20 minutes with a frequency of 10 Hz and 35%, with trans-cranial electrom
Treatment - Devices
Treatment - Drugs
In the treatment group, patients treated with electromagnetic therapy and 3 weeks for 6 sessions, each session 20 minutes with a frequency of 10 Hz and 35%, with trans-cranial electromagnetic therapy
Alprazolam 1 mg tablet daily in the control group patients were treated for 3 weeks,Controls to prevent patients from the placebo effect of the electromagnetic device therapy for 6 sessions in 3 weeks

Sponsors

Ardebil University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1.According to the DSM-IV criteria, their diagnosis has been determined 2. Their insomnia has lasted for 3 weeks 3.The patient didn't have other problems such as PUD,COPD,IHD,CHF,CVA,Asthmaand etc Exclusion criteria: 1.Happening side effects 2.Not appropriate participation of patients

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Insomnia. Timepoint: The patients in 3 periods before the study and immediately after the treatment and 1 month after treatment were evaluated. Method of measurement: The questionnaire Pitssburgh Sleep Quality Index(PSQI) also the questionnaire Insomnia Severity Index (ISI).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarid Gossili

Ardebil University Of Medical Sciences

farid_gossili@yahoo.com+98 45 1771 5737

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026